🇺🇸 wasp venom in United States

15 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 15

Most-reported reactions

1. Hypersensitivity — 3 reports (20%)
2. Anaphylactic Reaction — 2 reports (13.33%)
3. Drug Interaction — 2 reports (13.33%)
4. Injection Site Erythema — 2 reports (13.33%)
5. Anxiety — 1 report (6.67%)
6. Chest Discomfort — 1 report (6.67%)
7. Conjunctival Hyperaemia — 1 report (6.67%)
8. Erythema Of Eyelid — 1 report (6.67%)
9. Flushing — 1 report (6.67%)
10. Injection Site Induration — 1 report (6.67%)

Source database →

Frequently asked questions

Is wasp venom approved in United States?

wasp venom does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for wasp venom in United States?

Allergopharma GmbH & Co. KG is the originator. The local marketing authorisation holder may differ — check the official source linked above.